Medicinal Plants as Sources of Active Molecules Against COVID-19 von Benarba, Bachir, Pandiella, Atanasio

Volltext

Resistance to Antibody-Drug Conjugates von García-Alonso, Sara, Ocaña, Alberto, Pandiella, Atanasio

Volltext

PDCD4 limits prooncogenic neuregulin-ErbB signaling von Montero, Juan Carlos, Pandiella, Atanasio

Volltext

HER2 heterogeneity and resistance to anti-HER2 antibody-drug conjugates von Ocana, Alberto, Amir, Eitan, Pandiella, Atanasio

Volltext

Neutrophils in cancer: prognostic role and therapeutic strategies von Ocana, Alberto, Nieto-Jiménez, Cristina, Pandiella, Atanasio, Templeton, Arnoud J

Volltext

Proteolysis targeting chimeras (PROTACs) in cancer therapy von Ocana, Alberto, Pandiella, Atanasio

Volltext

Targeting oncogenic vulnerabilities in triple negative breast cancer: biological bases and ongoing clinical studies von Ocana, Alberto, Pandiella, Atanasio

Volltext

Inhibition of Src Family Kinases and Receptor Tyrosine Kinases by Dasatinib: Possible Combinations in Solid Tumors von MONTERO, Juan Carlos, SEOANE, Samuel, OCANA, Alberto, PANDIELLA, Atanasio

Volltext

HER3 in cancer: from the bench to the bedside von Gandullo-Sánchez, Lucía, Ocaéa, Alberto, Pandiella, Atanasio

Volltext

HER3 Overexpression and Survival in Solid Tumors: A Meta-analysis von OCANA, Alberto, VERA-BADILLO, Francisco, SERUGA, Bostjan, TEMPLETON, Arnoud, PANDIELLA, Atanasio, AMIR, Eitan

Volltext

Antibody Conjugation of Nanoparticles as Therapeutics for Breast Cancer Treatment von Juan, Alberto, Cimas, Francisco J., Bravo, Ivan, Pandiella, Atanasio, Ocana, Alberto, Alonso-Moreno, Carlos

Volltext

Resistance to the Antibody-Drug Conjugate T-DM1 Is Based in a Reduction in Lysosomal Proteolytic Activity von Ríos-Luci, Carla, García-Alonso, Sara, Díaz-Rodríguez, Elena, Nadal-Serrano, Mercedes, Arribas, Joaquín, Ocaña, Alberto, Pandiella, Atanasio

Volltext

Trastuzumab Emtansine: Mechanisms of Action and Resistance, Clinical Progress, and Beyond von Garcia-Alonso, Sara, Ocana, Alberto, Pandiella, Atanasio

Volltext

An Overview of Antibody Conjugated Polymeric Nanoparticles for Breast Cancer Therapy von Juan, Alberto, Cimas, Francisco J., Bravo, Ivan, Pandiella, Atanasio, Ocana, Alberto, Alonso-Moreno, Carlos

Volltext

Ocoxin Oral Solution Triggers DNA Damage and Cell Death in Ovarian Cancer von Almaraz-Postigo, Sheila, Sanz, Eduardo, Pandiella, Atanasio, Díaz-Rodríguez, Elena

Volltext

Immune Checkpoint Inhibitors and RAS–ERK Pathway-Targeted Drugs as Combined Therapy for the Treatment of Melanoma von Morante, Marta, Pandiella, Atanasio, Crespo, Piero, Herrero, Ana

Volltext

Activity of BET-proteolysis targeting chimeric (PROTAC) compounds in triple negative breast cancer von Noblejas-López, María Del Mar, Nieto-Jimenez, Cristina, Burgos, Miguel, Gómez-Juárez, Mónica, Montero, Juan Carlos, Esparís-Ogando, Azucena, Pandiella, Atanasio, Galán-Moya, Eva M, Ocaña, Alberto

Volltext

HER3 targeting with an antibody‐drug conjugate bypasses resistance to anti‐HER2 therapies von Gandullo‐Sánchez, Lucía, Capone, Emily, Ocaña, Alberto, Iacobelli, Stefano, Sala, Gianluca, Pandiella, Atanasio

Volltext

Activation of the PI3K/mTOR/AKT pathway and survival in solid tumors: systematic review and meta-analysis von Ocana, Alberto, Vera-Badillo, Francisco, Al-Mubarak, Mustafa, Templeton, Arnoud J, Corrales-Sanchez, Verónica, Diez-Gonzalez, Laura, Cuenca-Lopez, María D, Seruga, Bostjan, Pandiella, Atanasio, Amir, Eitan

Volltext

Considerations for the clinical development of immuno-oncology agents in cancer von Pandiella, Atanasio, Calvo, Emiliano, Moreno, Victor, Amir, Eitan, Templeton, Arnoud, Ocana, Alberto

Volltext